SCHEMBL4617166

SCHEMBL4617166

COc1cc(OC)c(C)c(C(C)O[C]=O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.37
ADRA2A P08913 1/20 0.37
ADRA1A P35348 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPK1 P28482 2/20 0.36
BLM P54132 1/20 0.36
HTT P42858 1/20 0.36
ALDH1A1 P00352 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP1A2 P05177 1/20 0.35
NQO2 P16083 2/20 0.34
CYP19A1 P11511 1/20 0.34
KDM4E B2RXH2 2/20 0.34
LMNA P02545 2/20 0.34
GAA P10253 2/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
GLA P06280 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9068972 0.79 HTT (0.41) CYP2D6ADRA2AADRA1AMEN1KMT2A
SCHEMBL19122094 0.78 POLB (0.43) CYP2D6ADRA2AADRA1AMEN1KMT2A
SCHEMBL4711687 0.75 CYP2D6 (0.37) CYP2D6ADRA2AADRA1AMEN1KMT2A
SCHEMBL1133802 0.73 ALDH1A1 (0.44) CYP2D6MEN1KMT2AALDH1A1CYP3A4
SCHEMBL862161 0.71 ALDH1A1 (0.56) MEN1KMT2AMAPK1ALDH1A1CYP3A4
SCHEMBL8716433 0.69 RAB9A (0.46) CYP2D6MEN1KMT2AMAPK1ALDH1A1
SCHEMBL385533 0.69
SCHEMBL7399351 0.68 ESR1 (0.40) KMT2AALDH1A1
SCHEMBL8066434 0.66 ALDH1A1 (0.44) CYP2D6MEN1KMT2AMAPK1ALDH1A1
SCHEMBL12141429 0.65 ALDH1A1 (0.48) MEN1KMT2AMAPK1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081893-A1 INTRACELLULAR TARGETING OF OLIGONUCLEOTIDES ENTRADA THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed
EP-1891090-A2 MACROCYCLIC GHRELIN RECEPTOR ANTAGONISTS AND INVERSE AGONISTS AND METHODS OF USING THE SAME Tranzyme Pharma, Inc. (US) 2008-02-27 EP disclosed
WO-2006137974-A2 MACROCYCLIC GHRELIN RECEPTOR ANTAGONISTS AND INVERSE AGONISTS AND METHODS OF USING THE SAME TRANZYME PHARMA, INC. (US) 2006-12-28 WO disclosed
EP-0707564-A1 DIFLUORO STATONE ANALOGS MERRELL PHARMACEUTICALS INC. (US) 1996-04-24 EP disclosed